You are here

Article info

Article menu
Download PDFPDF
Letter
Rituximab in moderate to severe non-renal systemic lupus erythematosus: a reanalysis of the EXPLORER study

Authors

  • Marc Scherlinger Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Bordeaux, France Université de Bordeaux, Bordeaux, France CNRS-UMR 5164 Immuno ConcEpT, Bordeaux, France PubMed articlesGoogle scholar articles
  • Claire Carcaud Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Bordeaux, France Université de Bordeaux, Bordeaux, France PubMed articlesGoogle scholar articles
  • Marie-Elise Truchetet Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Bordeaux, France Université de Bordeaux, Bordeaux, France CNRS-UMR 5164 Immuno ConcEpT, Bordeaux, France PubMed articlesGoogle scholar articles
  • Thomas Barnetche Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Bordeaux, France PubMed articlesGoogle scholar articles
  • Pierre Duffau Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Bordeaux, France Université de Bordeaux, Bordeaux, France CNRS-UMR 5164 Immuno ConcEpT, Bordeaux, France PubMed articlesGoogle scholar articles
  • Lionel Couzi Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Bordeaux, France Université de Bordeaux, Bordeaux, France CNRS-UMR 5164 Immuno ConcEpT, Bordeaux, France PubMed articlesGoogle scholar articles
  • Julien Seneschal Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Bordeaux, France Université de Bordeaux, Bordeaux, France PubMed articlesGoogle scholar articles
  • Patrick Blanco Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Bordeaux, France Université de Bordeaux, Bordeaux, France CNRS-UMR 5164 Immuno ConcEpT, Bordeaux, France PubMed articlesGoogle scholar articles
  • Estibaliz Lazaro Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Bordeaux, France Université de Bordeaux, Bordeaux, France CNRS-UMR 5164 Immuno ConcEpT, Bordeaux, France PubMed articlesGoogle scholar articles
  • Christophe Richez Centre Hospitalier Universitaire de Bordeaux, FHU ACRONIM, Bordeaux, France Université de Bordeaux, Bordeaux, France CNRS-UMR 5164 Immuno ConcEpT, Bordeaux, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Estibaliz Lazaro; estibaliz.lazaro{at}chu-bordeaux.fr; Dr Christophe Richez, CNRS-UMR, 5164 Immuno ConcEpT, 146 rue Léo Saignat, 33076 Bordeaux, France; christophe.richez{at}chu-bordeaux.fr
View Full Text

Citation

Scherlinger M, Carcaud C, Truchetet M, et al
Rituximab in moderate to severe non-renal systemic lupus erythematosus: a reanalysis of the EXPLORER study
Annals of the Rheumatic Diseases 2019;78:1007-1010.

Publication history

  • Received November 27, 2018
  • Revised December 20, 2018
  • Accepted December 20, 2018
  • First published January 4, 2019.
Online issue publication 
May 12, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.